Sanyou Biopharmaceuticals (三优生物)

Sanyou Biopharmaceuticals is a Shanghai-based biopharmaceutical company, founded in 2015, focused on the research, development and commercialization of innovative drugs, with antibody discovery at its core. Its AI-driven R&D system pairs the AI-STAL super-trillion-scale proprietary molecule library and the SAI-DA accelerator, which combines dozens of AI algorithms with wet-lab validation across preclinical development, with Clicklinks, an open-innovation platform for co-creating original new drugs. The company serves a global network of more than 2,000 pharmaceutical and biotech partners under 100+ collaborative R&D agreements, supported by over 20,000 square meters of R&D and GMP facilities.

  • Series C+
  • AI/ML
  • Biotechnology
  • Clinical Trials
  • Pharmaceuticals
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 9, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 9, 2026

    CNY 14.9M

    Series C+

    Led by Zero2IPO Industrial Investment (清科产投)

    • Zero2IPO Industrial Investment (清科产投)

    Article coming soon.

Pricing

Research Sanyou Biopharmaceuticals (三优生物) — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Sanyou Biopharmaceuticals (三优生物) is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational